Dr. Cosby is a contributing Physician Scientist / Scientific Consultant based in Rockville, Maryland, U.S.A. He received his medical degree from Howard University College of Medicine and research training at the National Heart Lung Blood Institute/National Institutes of Health and Johns Hopkins University School of Medicine.

Dr. Cosby is a contributing Physician Scientist / Scientific Consultant based in Rockville, Maryland, U.S.A. He received his medical degree from Howard University College of Medicine and research training at the National Heart Lung Blood Institute/National Institutes of Health and Johns Hopkins University School of Medicine. He is scientifically noted for his successful management of an FDA-approved clinical trial which was featured in the New York Times (https://www.nytimes.com/2003/11/03/us/study-finds-that-nitrites-in-the-body-greatly-aid-blood-flow.html) and Nature Medicine (https://www.nature.com/articles/nm954).

In addition, he has published some of his other scientific writings in quality journals such as J Vasc Surg, Ann Vasc Surg, Circulation, Blood, J Cardiovas Magn Reson, J American College Cardiology, J MRI, Stem Cell, and Nature Medicine. He has written key documents for his professional clients such as academic publications (abstracts, posters, manuscripts, case reports, advisory board reports), and regulatory submissions (CSRs, IBs, protocols, consent forms, and INDs). Dr. Cosby has also collaborated with the pharmaceutical industry with timely written articles such as (New Technology to Connect Physicians and Pharmaceutical Sales Representative During the Global Coronavirus Pandemic, Technology is the Key to Streamlining the Acquisition, Analysis and Sharing of Clinical Trial Data, An Open Letter to Pharma CEOs from a MD: Advice for Streamlining Clinical Trials and the Drug Development Process, and Breaking Down Barriers Between Pharmaceutical Organizations and Key Stakeholders with Innovative Technologies – http://www.p360.com).

Incredibly, Dr. Cosby’s medical expertise has allowed him to leverage and influence some well-known organizations such as the National Institutes of Health, the National Cancer Institute, Sobi Pharmaceuticals, Vanda Pharmaceuticals, Denver Health & Hospital Authority, Tongji Medical Hospital (Wuhan, China), Bio-Trac, Inc, Emory School of Medicine, George Washington University School Medicine and the Center for Disease Control and Prevention.

Dr. Cosby uses his biomedical science presence to facilitate collaborative partnerships among experts from the business community, academia, Big Pharma, and the federal government. He is an advocate for scientific excellence while engaging translational medicine, basic research, and the federal regulatory process. His key therapeutic areas of interest include (Surgery, Cardiology, Mental health disorders, Neurology, Diabetes, Hematology, Oncology, Endocrinology, Rheumatology, Respiratory disease, Women & Men’s health) and the drug development fields of (cardiovascular science, cancer research, clinical trial management, vaccines, and nitric oxide/nitrite research).